🚀 VC round data is live in beta, check it out!
Trajan Group Holdings Valuation Multiples
Discover revenue and EBITDA valuation multiples for Trajan Group Holdings and similar public comparables like Anatolia Geneworks, Pulmonx, AOTI, HeartBeam and more.
Trajan Group Holdings Overview
About Trajan Group Holdings
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
Founded
2011
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$90M
Trajan Group Holdings Financials
Trajan Group Holdings reported last 12-month revenue of $116M and EBITDA of $11M.
In the same LTM period, Trajan Group Holdings generated $45M in gross profit, $11M in EBITDA, and $2M in net income.
Revenue (LTM)
Trajan Group Holdings P&L
In the most recent fiscal year, Trajan Group Holdings reported revenue of $117M and EBITDA of $10M.
Trajan Group Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $116M | XXX | $117M | XXX | XXX | XXX |
| Gross Profit | $45M | XXX | $45M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $11M | XXX | $10M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $2M | XXX | $500K | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | — | — | $21M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Trajan Group Holdings Stock Performance
Trajan Group Holdings has current market cap of $58M, and enterprise value of $90M.
Market Cap Evolution
Trajan Group Holdings' stock price is $0.38.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $90M | $58M | (0.9%) | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTrajan Group Holdings Valuation Multiples
Trajan Group Holdings trades at 0.8x EV/Revenue multiple, and 8.4x EV/EBITDA.
EV / Revenue (LTM)
Trajan Group Holdings Financial Valuation Multiples
As of March 7, 2026, Trajan Group Holdings has market cap of $58M and EV of $90M.
Equity research analysts estimate Trajan Group Holdings' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Trajan Group Holdings has a P/E ratio of 25.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $58M | XXX | $58M | XXX | XXX | XXX |
| EV (current) | $90M | XXX | $90M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 8.4x | XXX | 8.9x | XXX | XXX | XXX |
| EV/EBIT | 18.2x | XXX | 25.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | 2.0x | XXX | XXX | XXX |
| P/E | 25.2x | XXX | 116.6x | XXX | XXX | XXX |
| EV/FCF | 27.8x | XXX | 19.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Trajan Group Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Trajan Group Holdings Margins & Growth Rates
Trajan Group Holdings' revenue in the last 12 month grew by 8%.
Trajan Group Holdings' rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Trajan Group Holdings' rule of X is 29% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Trajan Group Holdings Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 17% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 29% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 7% | XXX | 29% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 36% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Trajan Group Holdings Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Anatolia Geneworks | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulmonx | XXX | XXX | XXX | XXX | XXX | XXX |
| AOTI | XXX | XXX | XXX | XXX | XXX | XXX |
| HeartBeam | XXX | XXX | XXX | XXX | XXX | XXX |
| Bactiguard | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Trajan Group Holdings M&A Activity
Trajan Group Holdings acquired XXX companies to date.
Last acquisition by Trajan Group Holdings was on XXXXXXXX, XXXXX. Trajan Group Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Trajan Group Holdings
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTrajan Group Holdings Investment Activity
Trajan Group Holdings invested in XXX companies to date.
Trajan Group Holdings made its latest investment on XXXXXXXX, XXXXX. Trajan Group Holdings invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Trajan Group Holdings
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Trajan Group Holdings
| When was Trajan Group Holdings founded? | Trajan Group Holdings was founded in 2011. |
| Where is Trajan Group Holdings headquartered? | Trajan Group Holdings is headquartered in Australia. |
| Is Trajan Group Holdings publicly listed? | Yes, Trajan Group Holdings is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Trajan Group Holdings? | Trajan Group Holdings trades under TRJ ticker. |
| When did Trajan Group Holdings go public? | Trajan Group Holdings went public in 2021. |
| Who are competitors of Trajan Group Holdings? | Trajan Group Holdings main competitors are Anatolia Geneworks, Pulmonx, AOTI, HeartBeam. |
| What is the current market cap of Trajan Group Holdings? | Trajan Group Holdings' current market cap is $58M. |
| What is the current revenue of Trajan Group Holdings? | Trajan Group Holdings' last 12 months revenue is $116M. |
| What is the current revenue growth of Trajan Group Holdings? | Trajan Group Holdings revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Trajan Group Holdings? | Current revenue multiple of Trajan Group Holdings is 0.8x. |
| Is Trajan Group Holdings profitable? | Yes, Trajan Group Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Trajan Group Holdings? | Trajan Group Holdings' last 12 months EBITDA is $11M. |
| What is Trajan Group Holdings' EBITDA margin? | Trajan Group Holdings' last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Trajan Group Holdings? | Current EBITDA multiple of Trajan Group Holdings is 8.4x. |
| What is the current FCF of Trajan Group Holdings? | Trajan Group Holdings' last 12 months FCF is $3M. |
| What is Trajan Group Holdings' FCF margin? | Trajan Group Holdings' last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Trajan Group Holdings? | Current FCF multiple of Trajan Group Holdings is 27.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.